Gapping down
In reaction to disappointing earnings/guidance: SZYM -35.8%, CSOD -19.2%, TXTR -18.5%, GNW -16.5%, BCOR -16.1%, WWWW -16%, TNGO -13.6%, MCP -13.5%, GNRC -11.5%, Z -8.5%, SB -8.1%, WBMD -7.9%, BIOS -7.1%, QCOM -6.2%, KLIC -6.1%, LPSN -6%, CF -5.4%, TEAR -4.1%, TS -4%, NSM -4%, MDWD -3.8%, THOR -3.8%, PODD -3.8%, CYNI -3.7%, FOXF -3.1%, AES -2.9%, WIN -2.3%, PRU -2.1%, HDNG -2%, IO -1.9%, PESI -1.9%, ACLS -1.7%, EVHC -1.6%, CLR -1.5%, PRGO -1.1%, EFC -1%, TEG -0.9%, SCTY -0.8%
M&A news: PRGO -1.1% (to acquire Omega Pharma NV for EUR 3.6 bln...ALSO reported earnings)
Select Brazil related names showing weakness: PBR.A -6.1%, GGB -3.1%, TSU -3%, VIV -2.9%
Other news: AEZS -48.1% (FDA issues complete response letter for Aeterna Zentaris' Macrilen NDA in adult growth hormone deficiency), SZYM -35.8% (Solazyme and Versalis, the chemical subsidiary of Eni S.p.A. (E) , announced a partnership to expand the commercial use of Encapso) BAH -4.4% (announced the sale of an aggregate of 10 mln shares of Class A common stock by an affiliate of The Carlyle Group ), ABGB -2.9% (announces proposed offering of $255 million notes ), WDC -2.2% (announces secondary offering of 5,434,783 shares of its common stock by Hitachi, Ltd.), PKT -1.1% (Enova International to replace Procera Networks in S&P 600), INTC -0.5% (on QCOM results)
Analyst comments: LYG -1% (downgraded to Mkt Perform from Outperform at Bernstein), DUK -0.7% (downgraded to Hold from Buy at Deutsche Bank), HRL -0.6% (downgraded to Mkt Perform from Outperform at BMO Capital Mkts)